377 related articles for article (PubMed ID: 10406404)
1. The use of oral pilocarpine in xerostomia and Sjögren's syndrome.
Nusair S; Rubinow A
Semin Arthritis Rheum; 1999 Jun; 28(6):360-7. PubMed ID: 10406404
[TBL] [Abstract][Full Text] [Related]
2. Systemic pilocarpine for treatment of xerostomia.
Berk L
Expert Opin Drug Metab Toxicol; 2008 Oct; 4(10):1333-40. PubMed ID: 18798702
[TBL] [Abstract][Full Text] [Related]
3. Oral pilocarpine HCl stimulates labial (minor) salivary gland flow in patients with Sjögren's syndrome.
Rhodus NL
Oral Dis; 1997 Jun; 3(2):93-8. PubMed ID: 9467349
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of orally administered pilocarpine hydrochloride for patients with juvenile-onset Sjögren's syndrome.
Tomiita M; Takei S; Kuwada N; Nonaka Y; Saito K; Shimojo N; Kohno Y
Mod Rheumatol; 2010 Oct; 20(5):486-90. PubMed ID: 20517630
[TBL] [Abstract][Full Text] [Related]
5. Pilocarpine and artificial saliva for the treatment of xerostomia and xerophthalmia in Sjögren syndrome: a double-blind randomized controlled trial.
Cifuentes M; Del Barrio-Díaz P; Vera-Kellet C
Br J Dermatol; 2018 Nov; 179(5):1056-1061. PubMed ID: 29432648
[TBL] [Abstract][Full Text] [Related]
6. Post-radiation severe xerostomia relieved by pilocarpine: a prospective French cooperative study.
Horiot JC; Lipinski F; Schraub S; Maulard-Durdux C; Bensadoun RJ; Ardiet JM; Bolla M; Coscas Y; Baillet F; Coche-Dequéant B; Urbajtel M; Montbarbon X; Bourdin S; Wibault M; Alfonsi M; Calais G; Desprez P; Pene F; Lapeyre M; Vinke J; Maral J
Radiother Oncol; 2000 Jun; 55(3):233-9. PubMed ID: 11041775
[TBL] [Abstract][Full Text] [Related]
7. Benefits of long-term pilocarpine due to increased muscarinic acetylcholine receptor 3 in salivary glands.
Minagi HO; Ikai K; Araie T; Sakai M; Sakai T
Biochem Biophys Res Commun; 2018 Sep; 503(2):1098-1102. PubMed ID: 29953856
[TBL] [Abstract][Full Text] [Related]
8. Salivary gland ultrasonography as a primary imaging tool for predicting efficacy of xerostomia treatment in patients with Sjögren's syndrome.
Takagi Y; Sumi M; Nakamura H; Sato S; Kawakami A; Nakamura T
Rheumatology (Oxford); 2016 Feb; 55(2):237-45. PubMed ID: 26338664
[TBL] [Abstract][Full Text] [Related]
9. Artificial saliva products and drugs to treat xerostomia.
Wynn RL; Meiller TF
Gen Dent; 2000; 48(6):630-6. PubMed ID: 12004654
[No Abstract] [Full Text] [Related]
10. Effect of Pilocarpine on impaired salivary secretion in patients with Sjögren's syndrome.
Jorkjend L; Bergenholtz A; Johansson AK; Johansson A
Swed Dent J; 2008; 32(2):49-56. PubMed ID: 18700333
[TBL] [Abstract][Full Text] [Related]
11. Re: Researchers make slow headway in managing dry mouth.
LeVeque F
J Natl Cancer Inst; 1997 Dec; 89(24):1894-5. PubMed ID: 9414180
[No Abstract] [Full Text] [Related]
12. Pilocarpine treatment of xerostomia in head and neck patients.
Leek H; Albertsson M
Micron; 2002; 33(2):153-5. PubMed ID: 11567884
[TBL] [Abstract][Full Text] [Related]
13. Oral pilocarpine for symptomatic relief of keratoconjunctivitis sicca in patients with Sjögren's syndrome. The MGI PHARMA Sjögren's Syndrome Study Group.
Nelson JD; Friedlaender M; Yeatts RP; Yee R; McDermott M; Orlin S; Gallagher SC; Shrotriya RC
Adv Exp Med Biol; 1998; 438():979-83. PubMed ID: 9634998
[No Abstract] [Full Text] [Related]
14. World Workshop on Oral Medicine VII: Immunobiologics for salivary gland disease in Sjögren's syndrome: A systematic review.
Gueiros LA; France K; Posey R; Mays JW; Carey B; Sollecito TP; Setterfield J; Woo SB; Culton D; Payne AS; Lodi G; Greenberg MS; De Rossi S
Oral Dis; 2019 Jun; 25 Suppl 1(Suppl 1):102-110. PubMed ID: 31140693
[TBL] [Abstract][Full Text] [Related]
15. Buccal drug delivery technologies for patient-centred treatment of radiation-induced xerostomia (dry mouth).
Malallah OS; Garcia CMA; Proctor GB; Forbes B; Royall PG
Int J Pharm; 2018 Apr; 541(1-2):157-166. PubMed ID: 29425763
[TBL] [Abstract][Full Text] [Related]
16. Salivary gland dysfunction and xerostomia in Sjögren's syndrome.
Jensen SB; Vissink A
Oral Maxillofac Surg Clin North Am; 2014 Feb; 26(1):35-53. PubMed ID: 24287192
[TBL] [Abstract][Full Text] [Related]
17. A randomized study to assess the effectiveness of orally administered pilocarpine during and after radiotherapy of head and neck cancer.
Nyárády Z; Németh A; Bán A; Mukics A; Nyárády J; Ember I; Olasz L
Anticancer Res; 2006; 26(2B):1557-62. PubMed ID: 16619571
[TBL] [Abstract][Full Text] [Related]
18. Parasympathomimetic drugs for the treatment of salivary gland dysfunction due to radiotherapy.
Davies AN; Thompson J
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD003782. PubMed ID: 26436597
[TBL] [Abstract][Full Text] [Related]
19. A new medication for treatment of dry mouth in Sjögren's syndrome.
al-Hashimi I; Taylor SE
Tex Dent J; 2001 Apr; 118(3):262-6. PubMed ID: 11404944
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of a commercially available oral moisturizer in relieving signs and symptoms of xerostomia in postirradiation head and neck cancer patients and patients with Sjögren's syndrome.
Rhodus NL; Bereuter J
J Otolaryngol; 2000 Feb; 29(1):28-34. PubMed ID: 10709169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
